EUA
Lucira by Pfizer COVID-19 & Flu Test
FDA Emergency Use Authorization · Pfizer Inc. · Sep 17, 2024
Key facts
| Product | Lucira by Pfizer COVID-19 & Flu Test |
|---|---|
| Company | Pfizer Inc. |
| Product type | RT-LAMP, Multiple Targets, Multi-analyte |
| Date | Sep 17, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: